臨床試驗

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

NCT：NCT07816185 · RECRUITING

NCT IDNCT07816185

狀態RECRUITING

開始日期2026-08-31

完成時間2029-08-31

SponsorPulmovant, Inc. (INDUSTRY)

First posted2026-09-11

Last updated2026-09-11

簡要摘要

A Phase 3, Multicenter, Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Mosliciguat in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。